Global Nucleic Acid Amplification Detection and Diagnostics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Nucleic Acid Amplification Detection and Diagnostics market size will reach US$ million by 2031.
Nucleic acid amplification technologies are used for the rapid and accurate diagnosis of chronic and infectious diseases. The nucleic acid amplification is one of the important tool for wide aspects of life science technologies including, clinical medicine development, diagnosis of infectious diseases, and gene cloning.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Nucleic Acid Amplification Detection and Diagnostics Industry Forecast” looks at past sales and reviews total world Nucleic Acid Amplification Detection and Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Amplification Detection and Diagnostics sales for 2025 through 2031. With Nucleic Acid Amplification Detection and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Amplification Detection and Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid Amplification Detection and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic Acid Amplification Detection and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Amplification Detection and Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Amplification Detection and Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Amplification Detection and Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Amplification Detection and Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Nucleic acid amplification technologies are used for the rapid and accurate diagnosis of chronic and infectious diseases. The nucleic acid amplification is one of the important tool for wide aspects of life science technologies including, clinical medicine development, diagnosis of infectious diseases, and gene cloning.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Nucleic Acid Amplification Detection and Diagnostics Industry Forecast” looks at past sales and reviews total world Nucleic Acid Amplification Detection and Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Amplification Detection and Diagnostics sales for 2025 through 2031. With Nucleic Acid Amplification Detection and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Amplification Detection and Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid Amplification Detection and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic Acid Amplification Detection and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Amplification Detection and Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Amplification Detection and Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Amplification Detection and Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Amplification Detection and Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Polymerase Chain Reaction (PCR)
- Next Generation Sequencing (NGS)
- Isothermal Amplification Technology
- Direct Nucleic Acid Detection
- CRISPR-Cas9
- Hospital and Clinics
- Diagnostic Centers
- Research Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BD
- BioMerieux SA
- BIO-RAD LABORATORIES INC.
- THERMO FISHER SCIENTIFIC INC.
- Illumina, Inc.
- Danaher
- QIAGEN
- Abbott
- Meridian Bioscience, Inc.
- F. Hoffmann-La Roche Ltd.
- PreAnalytiX
- Eiken Chemical
- Lucigen
- OptiGene
- NEB
- Quidel Corporation
- Promega
- Hologic
- Ustar
- Grifols
- Nugen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid Amplification Detection and Diagnostics Market Size (2020-2031)
2.1.2 Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nucleic Acid Amplification Detection and Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Nucleic Acid Amplification Detection and Diagnostics Segment by Type
2.2.1 Polymerase Chain Reaction (PCR)
2.2.2 Next Generation Sequencing (NGS)
2.2.3 Isothermal Amplification Technology
2.2.4 Direct Nucleic Acid Detection
2.2.5 CRISPR-Cas9
2.3 Nucleic Acid Amplification Detection and Diagnostics Market Size by Type
2.3.1 Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Nucleic Acid Amplification Detection and Diagnostics Segment by Application
2.4.1 Hospital and Clinics
2.4.2 Diagnostic Centers
2.4.3 Research Institutes
2.4.4 Others
2.5 Nucleic Acid Amplification Detection and Diagnostics Market Size by Application
2.5.1 Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
3 NUCLEIC ACID AMPLIFICATION DETECTION AND DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Player
3.1.1 Global Nucleic Acid Amplification Detection and Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Nucleic Acid Amplification Detection and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID AMPLIFICATION DETECTION AND DIAGNOSTICS BY REGION
4.1 Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025)
4.2 Global Nucleic Acid Amplification Detection and Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2020-2025)
4.4 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2020-2025)
4.5 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025)
5.2 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025)
5.3 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025)
6.2 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025)
6.3 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025)
7.2 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025)
7.3 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID AMPLIFICATION DETECTION AND DIAGNOSTICS MARKET FORECAST
10.1 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Nucleic Acid Amplification Detection and Diagnostics Forecast
10.1.3 APAC Nucleic Acid Amplification Detection and Diagnostics Forecast
10.1.4 Europe Nucleic Acid Amplification Detection and Diagnostics Forecast
10.1.5 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Forecast
10.2 Americas Nucleic Acid Amplification Detection and Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.2.2 Canada Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.2.3 Mexico Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.2.4 Brazil Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.3 APAC Nucleic Acid Amplification Detection and Diagnostics Forecast by Region (2026-2031)
10.3.1 China Nucleic Acid Amplification Detection and Diagnostics Market Forecast
10.3.2 Japan Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.3.3 Korea Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.3.4 Southeast Asia Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.3.5 India Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.3.6 Australia Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.4 Europe Nucleic Acid Amplification Detection and Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.4.2 France Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.4.3 UK Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.4.4 Italy Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.4.5 Russia Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.5 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.5.2 South Africa Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.5.3 Israel Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.5.4 Turkey Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.6 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Type (2026-2031)
10.7 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nucleic Acid Amplification Detection and Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.1.3 BD Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 BioMerieux SA
11.2.1 BioMerieux SA Company Information
11.2.2 BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.2.3 BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 BioMerieux SA Main Business Overview
11.2.5 BioMerieux SA Latest Developments
11.3 BIO-RAD LABORATORIES INC.
11.3.1 BIO-RAD LABORATORIES INC. Company Information
11.3.2 BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.3.3 BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 BIO-RAD LABORATORIES INC. Main Business Overview
11.3.5 BIO-RAD LABORATORIES INC. Latest Developments
11.4 THERMO FISHER SCIENTIFIC INC.
11.4.1 THERMO FISHER SCIENTIFIC INC. Company Information
11.4.2 THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.4.3 THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 THERMO FISHER SCIENTIFIC INC. Main Business Overview
11.4.5 THERMO FISHER SCIENTIFIC INC. Latest Developments
11.5 Illumina, Inc.
11.5.1 Illumina, Inc. Company Information
11.5.2 Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.5.3 Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Illumina, Inc. Main Business Overview
11.5.5 Illumina, Inc. Latest Developments
11.6 Danaher
11.6.1 Danaher Company Information
11.6.2 Danaher Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.6.3 Danaher Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Danaher Main Business Overview
11.6.5 Danaher Latest Developments
11.7 QIAGEN
11.7.1 QIAGEN Company Information
11.7.2 QIAGEN Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.7.3 QIAGEN Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 QIAGEN Main Business Overview
11.7.5 QIAGEN Latest Developments
11.8 Abbott
11.8.1 Abbott Company Information
11.8.2 Abbott Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.8.3 Abbott Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Abbott Main Business Overview
11.8.5 Abbott Latest Developments
11.9 Meridian Bioscience, Inc.
11.9.1 Meridian Bioscience, Inc. Company Information
11.9.2 Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.9.3 Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Meridian Bioscience, Inc. Main Business Overview
11.9.5 Meridian Bioscience, Inc. Latest Developments
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Company Information
11.10.2 F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.10.3 F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.10.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.11 PreAnalytiX
11.11.1 PreAnalytiX Company Information
11.11.2 PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.11.3 PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 PreAnalytiX Main Business Overview
11.11.5 PreAnalytiX Latest Developments
11.12 Eiken Chemical
11.12.1 Eiken Chemical Company Information
11.12.2 Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.12.3 Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Eiken Chemical Main Business Overview
11.12.5 Eiken Chemical Latest Developments
11.13 Lucigen
11.13.1 Lucigen Company Information
11.13.2 Lucigen Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.13.3 Lucigen Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Lucigen Main Business Overview
11.13.5 Lucigen Latest Developments
11.14 OptiGene
11.14.1 OptiGene Company Information
11.14.2 OptiGene Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.14.3 OptiGene Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 OptiGene Main Business Overview
11.14.5 OptiGene Latest Developments
11.15 NEB
11.15.1 NEB Company Information
11.15.2 NEB Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.15.3 NEB Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 NEB Main Business Overview
11.15.5 NEB Latest Developments
11.16 Quidel Corporation
11.16.1 Quidel Corporation Company Information
11.16.2 Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.16.3 Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Quidel Corporation Main Business Overview
11.16.5 Quidel Corporation Latest Developments
11.17 Promega
11.17.1 Promega Company Information
11.17.2 Promega Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.17.3 Promega Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Promega Main Business Overview
11.17.5 Promega Latest Developments
11.18 Hologic
11.18.1 Hologic Company Information
11.18.2 Hologic Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.18.3 Hologic Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Hologic Main Business Overview
11.18.5 Hologic Latest Developments
11.19 Ustar
11.19.1 Ustar Company Information
11.19.2 Ustar Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.19.3 Ustar Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Ustar Main Business Overview
11.19.5 Ustar Latest Developments
11.20 Grifols
11.20.1 Grifols Company Information
11.20.2 Grifols Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.20.3 Grifols Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Grifols Main Business Overview
11.20.5 Grifols Latest Developments
11.21 Nugen
11.21.1 Nugen Company Information
11.21.2 Nugen Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.21.3 Nugen Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Nugen Main Business Overview
11.21.5 Nugen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid Amplification Detection and Diagnostics Market Size (2020-2031)
2.1.2 Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nucleic Acid Amplification Detection and Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Nucleic Acid Amplification Detection and Diagnostics Segment by Type
2.2.1 Polymerase Chain Reaction (PCR)
2.2.2 Next Generation Sequencing (NGS)
2.2.3 Isothermal Amplification Technology
2.2.4 Direct Nucleic Acid Detection
2.2.5 CRISPR-Cas9
2.3 Nucleic Acid Amplification Detection and Diagnostics Market Size by Type
2.3.1 Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Nucleic Acid Amplification Detection and Diagnostics Segment by Application
2.4.1 Hospital and Clinics
2.4.2 Diagnostic Centers
2.4.3 Research Institutes
2.4.4 Others
2.5 Nucleic Acid Amplification Detection and Diagnostics Market Size by Application
2.5.1 Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
3 NUCLEIC ACID AMPLIFICATION DETECTION AND DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Player
3.1.1 Global Nucleic Acid Amplification Detection and Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Nucleic Acid Amplification Detection and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID AMPLIFICATION DETECTION AND DIAGNOSTICS BY REGION
4.1 Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025)
4.2 Global Nucleic Acid Amplification Detection and Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2020-2025)
4.4 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2020-2025)
4.5 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025)
5.2 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025)
5.3 Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025)
6.2 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025)
6.3 APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025)
7.2 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025)
7.3 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID AMPLIFICATION DETECTION AND DIAGNOSTICS MARKET FORECAST
10.1 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Nucleic Acid Amplification Detection and Diagnostics Forecast
10.1.3 APAC Nucleic Acid Amplification Detection and Diagnostics Forecast
10.1.4 Europe Nucleic Acid Amplification Detection and Diagnostics Forecast
10.1.5 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Forecast
10.2 Americas Nucleic Acid Amplification Detection and Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.2.2 Canada Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.2.3 Mexico Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.2.4 Brazil Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.3 APAC Nucleic Acid Amplification Detection and Diagnostics Forecast by Region (2026-2031)
10.3.1 China Nucleic Acid Amplification Detection and Diagnostics Market Forecast
10.3.2 Japan Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.3.3 Korea Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.3.4 Southeast Asia Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.3.5 India Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.3.6 Australia Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.4 Europe Nucleic Acid Amplification Detection and Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.4.2 France Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.4.3 UK Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.4.4 Italy Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.4.5 Russia Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.5 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.5.2 South Africa Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.5.3 Israel Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.5.4 Turkey Market Nucleic Acid Amplification Detection and Diagnostics Forecast
10.6 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Type (2026-2031)
10.7 Global Nucleic Acid Amplification Detection and Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nucleic Acid Amplification Detection and Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.1.3 BD Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 BioMerieux SA
11.2.1 BioMerieux SA Company Information
11.2.2 BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.2.3 BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 BioMerieux SA Main Business Overview
11.2.5 BioMerieux SA Latest Developments
11.3 BIO-RAD LABORATORIES INC.
11.3.1 BIO-RAD LABORATORIES INC. Company Information
11.3.2 BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.3.3 BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 BIO-RAD LABORATORIES INC. Main Business Overview
11.3.5 BIO-RAD LABORATORIES INC. Latest Developments
11.4 THERMO FISHER SCIENTIFIC INC.
11.4.1 THERMO FISHER SCIENTIFIC INC. Company Information
11.4.2 THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.4.3 THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 THERMO FISHER SCIENTIFIC INC. Main Business Overview
11.4.5 THERMO FISHER SCIENTIFIC INC. Latest Developments
11.5 Illumina, Inc.
11.5.1 Illumina, Inc. Company Information
11.5.2 Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.5.3 Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Illumina, Inc. Main Business Overview
11.5.5 Illumina, Inc. Latest Developments
11.6 Danaher
11.6.1 Danaher Company Information
11.6.2 Danaher Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.6.3 Danaher Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Danaher Main Business Overview
11.6.5 Danaher Latest Developments
11.7 QIAGEN
11.7.1 QIAGEN Company Information
11.7.2 QIAGEN Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.7.3 QIAGEN Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 QIAGEN Main Business Overview
11.7.5 QIAGEN Latest Developments
11.8 Abbott
11.8.1 Abbott Company Information
11.8.2 Abbott Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.8.3 Abbott Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Abbott Main Business Overview
11.8.5 Abbott Latest Developments
11.9 Meridian Bioscience, Inc.
11.9.1 Meridian Bioscience, Inc. Company Information
11.9.2 Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.9.3 Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Meridian Bioscience, Inc. Main Business Overview
11.9.5 Meridian Bioscience, Inc. Latest Developments
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Company Information
11.10.2 F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.10.3 F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.10.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.11 PreAnalytiX
11.11.1 PreAnalytiX Company Information
11.11.2 PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.11.3 PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 PreAnalytiX Main Business Overview
11.11.5 PreAnalytiX Latest Developments
11.12 Eiken Chemical
11.12.1 Eiken Chemical Company Information
11.12.2 Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.12.3 Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Eiken Chemical Main Business Overview
11.12.5 Eiken Chemical Latest Developments
11.13 Lucigen
11.13.1 Lucigen Company Information
11.13.2 Lucigen Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.13.3 Lucigen Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Lucigen Main Business Overview
11.13.5 Lucigen Latest Developments
11.14 OptiGene
11.14.1 OptiGene Company Information
11.14.2 OptiGene Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.14.3 OptiGene Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 OptiGene Main Business Overview
11.14.5 OptiGene Latest Developments
11.15 NEB
11.15.1 NEB Company Information
11.15.2 NEB Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.15.3 NEB Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 NEB Main Business Overview
11.15.5 NEB Latest Developments
11.16 Quidel Corporation
11.16.1 Quidel Corporation Company Information
11.16.2 Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.16.3 Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Quidel Corporation Main Business Overview
11.16.5 Quidel Corporation Latest Developments
11.17 Promega
11.17.1 Promega Company Information
11.17.2 Promega Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.17.3 Promega Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Promega Main Business Overview
11.17.5 Promega Latest Developments
11.18 Hologic
11.18.1 Hologic Company Information
11.18.2 Hologic Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.18.3 Hologic Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Hologic Main Business Overview
11.18.5 Hologic Latest Developments
11.19 Ustar
11.19.1 Ustar Company Information
11.19.2 Ustar Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.19.3 Ustar Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Ustar Main Business Overview
11.19.5 Ustar Latest Developments
11.20 Grifols
11.20.1 Grifols Company Information
11.20.2 Grifols Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.20.3 Grifols Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Grifols Main Business Overview
11.20.5 Grifols Latest Developments
11.21 Nugen
11.21.1 Nugen Company Information
11.21.2 Nugen Nucleic Acid Amplification Detection and Diagnostics Product Offered
11.21.3 Nugen Nucleic Acid Amplification Detection and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Nugen Main Business Overview
11.21.5 Nugen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nucleic Acid Amplification Detection and Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Polymerase Chain Reaction (PCR)
Table 4. Major Players of Next Generation Sequencing (NGS)
Table 5. Major Players of Isothermal Amplification Technology
Table 6. Major Players of Direct Nucleic Acid Detection
Table 7. Major Players of CRISPR-Cas9
Table 8. Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
Table 11. Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
Table 14. Global Nucleic Acid Amplification Detection and Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Player (2020-2025)
Table 16. Nucleic Acid Amplification Detection and Diagnostics Key Players Head office and Products Offered
Table 17. Nucleic Acid Amplification Detection and Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Region (2020-2025)
Table 22. Global Nucleic Acid Amplification Detection and Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Country (2020-2025)
Table 26. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
Table 28. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
Table 30. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Region (2020-2025)
Table 32. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Country (2020-2025)
Table 36. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Nucleic Acid Amplification Detection and Diagnostics
Table 42. Key Market Challenges & Risks of Nucleic Acid Amplification Detection and Diagnostics
Table 43. Key Industry Trends of Nucleic Acid Amplification Detection and Diagnostics
Table 44. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. BD Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 49. BD Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 50. BD Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. BD Main Business
Table 52. BD Latest Developments
Table 53. BioMerieux SA Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 54. BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 55. BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. BioMerieux SA Main Business
Table 57. BioMerieux SA Latest Developments
Table 58. BIO-RAD LABORATORIES INC. Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 59. BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 60. BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. BIO-RAD LABORATORIES INC. Main Business
Table 62. BIO-RAD LABORATORIES INC. Latest Developments
Table 63. THERMO FISHER SCIENTIFIC INC. Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 64. THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 65. THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. THERMO FISHER SCIENTIFIC INC. Main Business
Table 67. THERMO FISHER SCIENTIFIC INC. Latest Developments
Table 68. Illumina, Inc. Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 69. Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 70. Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Illumina, Inc. Main Business
Table 72. Illumina, Inc. Latest Developments
Table 73. Danaher Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 74. Danaher Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 75. Danaher Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Danaher Main Business
Table 77. Danaher Latest Developments
Table 78. QIAGEN Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 79. QIAGEN Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 80. QIAGEN Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. QIAGEN Main Business
Table 82. QIAGEN Latest Developments
Table 83. Abbott Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 84. Abbott Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 85. Abbott Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Abbott Main Business
Table 87. Abbott Latest Developments
Table 88. Meridian Bioscience, Inc. Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 89. Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 90. Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Meridian Bioscience, Inc. Main Business
Table 92. Meridian Bioscience, Inc. Latest Developments
Table 93. F. Hoffmann-La Roche Ltd. Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 94. F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 95. F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. F. Hoffmann-La Roche Ltd. Main Business
Table 97. F. Hoffmann-La Roche Ltd. Latest Developments
Table 98. PreAnalytiX Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 99. PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 100. PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. PreAnalytiX Main Business
Table 102. PreAnalytiX Latest Developments
Table 103. Eiken Chemical Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 104. Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 105. Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Eiken Chemical Main Business
Table 107. Eiken Chemical Latest Developments
Table 108. Lucigen Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 109. Lucigen Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 110. Lucigen Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Lucigen Main Business
Table 112. Lucigen Latest Developments
Table 113. OptiGene Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 114. OptiGene Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 115. OptiGene Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. OptiGene Main Business
Table 117. OptiGene Latest Developments
Table 118. NEB Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 119. NEB Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 120. NEB Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. NEB Main Business
Table 122. NEB Latest Developments
Table 123. Quidel Corporation Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 124. Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 125. Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Quidel Corporation Main Business
Table 127. Quidel Corporation Latest Developments
Table 128. Promega Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 129. Promega Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 130. Promega Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. Promega Main Business
Table 132. Promega Latest Developments
Table 133. Hologic Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 134. Hologic Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 135. Hologic Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136. Hologic Main Business
Table 137. Hologic Latest Developments
Table 138. Ustar Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 139. Ustar Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 140. Ustar Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 141. Ustar Main Business
Table 142. Ustar Latest Developments
Table 143. Grifols Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 144. Grifols Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 145. Grifols Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 146. Grifols Main Business
Table 147. Grifols Latest Developments
Table 148. Nugen Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 149. Nugen Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 150. Nugen Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 151. Nugen Main Business
Table 152. Nugen Latest Developments
Table 1. Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nucleic Acid Amplification Detection and Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Polymerase Chain Reaction (PCR)
Table 4. Major Players of Next Generation Sequencing (NGS)
Table 5. Major Players of Isothermal Amplification Technology
Table 6. Major Players of Direct Nucleic Acid Detection
Table 7. Major Players of CRISPR-Cas9
Table 8. Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
Table 11. Nucleic Acid Amplification Detection and Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
Table 14. Global Nucleic Acid Amplification Detection and Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Player (2020-2025)
Table 16. Nucleic Acid Amplification Detection and Diagnostics Key Players Head office and Products Offered
Table 17. Nucleic Acid Amplification Detection and Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Region (2020-2025)
Table 22. Global Nucleic Acid Amplification Detection and Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Country (2020-2025)
Table 26. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
Table 28. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
Table 30. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Region (2020-2025)
Table 32. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Country (2020-2025)
Table 36. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Nucleic Acid Amplification Detection and Diagnostics
Table 42. Key Market Challenges & Risks of Nucleic Acid Amplification Detection and Diagnostics
Table 43. Key Industry Trends of Nucleic Acid Amplification Detection and Diagnostics
Table 44. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. BD Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 49. BD Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 50. BD Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. BD Main Business
Table 52. BD Latest Developments
Table 53. BioMerieux SA Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 54. BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 55. BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. BioMerieux SA Main Business
Table 57. BioMerieux SA Latest Developments
Table 58. BIO-RAD LABORATORIES INC. Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 59. BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 60. BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. BIO-RAD LABORATORIES INC. Main Business
Table 62. BIO-RAD LABORATORIES INC. Latest Developments
Table 63. THERMO FISHER SCIENTIFIC INC. Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 64. THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 65. THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. THERMO FISHER SCIENTIFIC INC. Main Business
Table 67. THERMO FISHER SCIENTIFIC INC. Latest Developments
Table 68. Illumina, Inc. Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 69. Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 70. Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Illumina, Inc. Main Business
Table 72. Illumina, Inc. Latest Developments
Table 73. Danaher Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 74. Danaher Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 75. Danaher Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Danaher Main Business
Table 77. Danaher Latest Developments
Table 78. QIAGEN Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 79. QIAGEN Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 80. QIAGEN Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. QIAGEN Main Business
Table 82. QIAGEN Latest Developments
Table 83. Abbott Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 84. Abbott Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 85. Abbott Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Abbott Main Business
Table 87. Abbott Latest Developments
Table 88. Meridian Bioscience, Inc. Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 89. Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 90. Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Meridian Bioscience, Inc. Main Business
Table 92. Meridian Bioscience, Inc. Latest Developments
Table 93. F. Hoffmann-La Roche Ltd. Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 94. F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 95. F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. F. Hoffmann-La Roche Ltd. Main Business
Table 97. F. Hoffmann-La Roche Ltd. Latest Developments
Table 98. PreAnalytiX Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 99. PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 100. PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. PreAnalytiX Main Business
Table 102. PreAnalytiX Latest Developments
Table 103. Eiken Chemical Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 104. Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 105. Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Eiken Chemical Main Business
Table 107. Eiken Chemical Latest Developments
Table 108. Lucigen Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 109. Lucigen Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 110. Lucigen Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Lucigen Main Business
Table 112. Lucigen Latest Developments
Table 113. OptiGene Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 114. OptiGene Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 115. OptiGene Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. OptiGene Main Business
Table 117. OptiGene Latest Developments
Table 118. NEB Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 119. NEB Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 120. NEB Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. NEB Main Business
Table 122. NEB Latest Developments
Table 123. Quidel Corporation Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 124. Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 125. Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Quidel Corporation Main Business
Table 127. Quidel Corporation Latest Developments
Table 128. Promega Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 129. Promega Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 130. Promega Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. Promega Main Business
Table 132. Promega Latest Developments
Table 133. Hologic Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 134. Hologic Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 135. Hologic Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136. Hologic Main Business
Table 137. Hologic Latest Developments
Table 138. Ustar Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 139. Ustar Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 140. Ustar Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 141. Ustar Main Business
Table 142. Ustar Latest Developments
Table 143. Grifols Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 144. Grifols Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 145. Grifols Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 146. Grifols Main Business
Table 147. Grifols Latest Developments
Table 148. Nugen Details, Company Type, Nucleic Acid Amplification Detection and Diagnostics Area Served and Its Competitors
Table 149. Nugen Nucleic Acid Amplification Detection and Diagnostics Product Offered
Table 150. Nugen Nucleic Acid Amplification Detection and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 151. Nugen Main Business
Table 152. Nugen Latest Developments
LIST OF FIGURES
Figure 1. Nucleic Acid Amplification Detection and Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nucleic Acid Amplification Detection and Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nucleic Acid Amplification Detection and Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Nucleic Acid Amplification Detection and Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type in 2024
Figure 10. Nucleic Acid Amplification Detection and Diagnostics in Hospital and Clinics
Figure 11. Global Nucleic Acid Amplification Detection and Diagnostics Market: Hospital and Clinics (2020-2025) & ($ millions)
Figure 12. Nucleic Acid Amplification Detection and Diagnostics in Diagnostic Centers
Figure 13. Global Nucleic Acid Amplification Detection and Diagnostics Market: Diagnostic Centers (2020-2025) & ($ millions)
Figure 14. Nucleic Acid Amplification Detection and Diagnostics in Research Institutes
Figure 15. Global Nucleic Acid Amplification Detection and Diagnostics Market: Research Institutes (2020-2025) & ($ millions)
Figure 16. Nucleic Acid Amplification Detection and Diagnostics in Others
Figure 17. Global Nucleic Acid Amplification Detection and Diagnostics Market: Others (2020-2025) & ($ millions)
Figure 18. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application in 2024
Figure 19. Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Player in 2024
Figure 20. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size 2020-2025 ($ millions)
Figure 25. Americas Nucleic Acid Amplification Detection and Diagnostics Value Market Share by Country in 2024
Figure 26. United States Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Region in 2024
Figure 31. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 33. China Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Country in 2024
Figure 40. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. United States Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Canada Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. China Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Japan Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. Korea Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. India Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. Australia Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. Germany Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. France Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. UK Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Italy Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. Russia Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Israel Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 78. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 1. Nucleic Acid Amplification Detection and Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nucleic Acid Amplification Detection and Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nucleic Acid Amplification Detection and Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Nucleic Acid Amplification Detection and Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type in 2024
Figure 10. Nucleic Acid Amplification Detection and Diagnostics in Hospital and Clinics
Figure 11. Global Nucleic Acid Amplification Detection and Diagnostics Market: Hospital and Clinics (2020-2025) & ($ millions)
Figure 12. Nucleic Acid Amplification Detection and Diagnostics in Diagnostic Centers
Figure 13. Global Nucleic Acid Amplification Detection and Diagnostics Market: Diagnostic Centers (2020-2025) & ($ millions)
Figure 14. Nucleic Acid Amplification Detection and Diagnostics in Research Institutes
Figure 15. Global Nucleic Acid Amplification Detection and Diagnostics Market: Research Institutes (2020-2025) & ($ millions)
Figure 16. Nucleic Acid Amplification Detection and Diagnostics in Others
Figure 17. Global Nucleic Acid Amplification Detection and Diagnostics Market: Others (2020-2025) & ($ millions)
Figure 18. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application in 2024
Figure 19. Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Player in 2024
Figure 20. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size 2020-2025 ($ millions)
Figure 25. Americas Nucleic Acid Amplification Detection and Diagnostics Value Market Share by Country in 2024
Figure 26. United States Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Region in 2024
Figure 31. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 33. China Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Country in 2024
Figure 40. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Nucleic Acid Amplification Detection and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. APAC Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. United States Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Canada Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. China Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Japan Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. Korea Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. India Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. Australia Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. Germany Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. France Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. UK Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Italy Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. Russia Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Israel Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
Figure 78. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Nucleic Acid Amplification Detection and Diagnostics Market Size 2026-2031 ($ millions)
More Publications
Global Ampicillin Market Growth 2025-2031
US$ 3,660.00
March 2025
93 pages
Global American Ginseng Extract Market Growth 2025-2031
US$ 3,660.00
October 2025
125 pages
Global Drospirenone and Ethinyl Estradiol Tablets Market Growth 2024-2030
US$ 3,660.00
June 2024
117 pages
Global Monopolar Electrosurgical Units Market Growth 2023-2029
US$ 3,660.00
March 2023
101 pages
Global Laboratory Stoppers Market Growth 2024-2030
US$ 3,660.00
September 2024
159 pages
